Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: Results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias

Journal of Cardiovascular Electrophysiology

Volumn 19, Issue 2, 2008, Pages 172-177

  Page, Richard L ^a,d   Pritchett, Edward L C ^b   Connolly, Stuart ^c   Wilkinson, William E ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c HAMILTON HEALTH SCIENCES   (Canada)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Antiarrhythmic medication; Asymptomatic; Atrial fibrillation; Azimilide; False recurrence; Silent atrial fibrillation

Indexed keywords

AZIMILIDE; PLACEBO;

ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG FATALITY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; HEADACHE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESPIRATORY TRACT INFECTION; TORSADE DES POINTES; UNSPECIFIED SIDE EFFECT;

ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; ATRIAL FLUTTER; ENDPOINT DETERMINATION; FEMALE; HUMANS; IMIDAZOLIDINES; MALE; PIPERAZINES; RECURRENCE; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

EID: 38849189256     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2007.00985.x     Document Type: Article

References (18)

1. Page RL : Clinical practice. Newly diagnosed atrial fibrillation. N Engl J Med 2004 351 : 2408 2416.
2. Page RL, Roden DM : Drug therapy for atrial fibrillation: Where do we go from here? Nat Rev Drug Discov 2005 4 : 899 910.
3. Connolly SJ, Schnell DJ, Page RL, Wilkinson WE, Marcello SR, Pritchett EL : Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation. Am J Cardiol 2001 88 : 974 979.
4. Page RL, Tilsch TW, Connolly SJ, Schnell DJ, Marcello SR, Wilkinson WE, Pritchett EL : Asymptomatic or "silent" atrial fibrillation: Frequency in untreated patients and patients receiving azimilide. Circulation 2003 107 : 1141 1145.
5. Pritchett EL, Page RL, Connolly SJ, Marcello SR, Schnell DJ, Wilkinson WE : Antiarrhythmic effects of azimilide in atrial fibrillation: Efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators. J Am Coll Cardiol 2000 36 : 794 802.
6. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL : Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994 89 : 224 227.
7. Kalbfleisch JD, Prentice RL : The Statistical Analysis of Failure Time Data. New York: John Wiley, 1980.
8. Hinkle LE Jr., Thaler HT : Clinical classification of cardiac deaths. Circulation 1982 65 : 457 464.
9. Camm AJ, Pratt CM, Schwartz PJ, Al-Khalidi HR, Spyt MJ, Holroyde MJ, Karam R, Sonnenblick EH, Brum JM : Mortality in patients after a recent myocardial infarction: A randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation 2004 109 : 990 996.
10. Pritchett EL, Marcello SR : Azimilide for atrial fibrillation: Clinical trial results and implications. Card Electrophysiol Rev 2003 7 : 215 219.
11. Kerr CR, Connolly SJ, Kowey P, Page RL, Pritchett EL, Ruda MY, Ruzyllo W, Wilkinson WE : Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease. Am J Cardiol 2006 98 : 215 218.
12. Pritchett EL, Kowey P, Connolly S, Page RL, Kerr C, Wilkinson WE : Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm. Am Heart J 2006 151 : 1043 1049.
13. Oral H, Veerareddy S, Good E, Hall B, Cheung P, Tamirisa K, Han J, Fortino J, Chugh A, Bogun F, Pelosi F Jr., Morady F : Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2004 15 : 920 924.
14. Hindricks G, Piorkowski C, Tanner H, Kobza R, Gerds-Li JH, Carbucicchio C, Kottkamp H : Perception of atrial fibrillation before and after radiofrequency catheter ablation: Relevance of asymptomatic arrhythmia recurrence. Circulation 2005 112 : 307 313.
15. Vasamreddy CR, Dalal D, Dong J, Cheng A, Spragg D, Lamiy SZ, Meininger G, Henrikson CA, Marine JE, Berger R, Calkins H : Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2006 17 : 134 139.
16. Bhandari AK, Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Cullen MT Jr., Hawkinson RW, Pritchett EL : Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: A transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. Am Heart J 1992 124 : 381 386.
17. Patten M, Maas R, Karim A, Muller HW, Simonovsky R, Meinertz T : Event-recorder monitoring in the diagnosis of atrial fibrillation in symptomatic patients: Subanalysis of the SOPAT trial. J Cardiovasc Electrophysiol 2006 17 : 1216 1220.
18. Klemm HU, Ventura R, Rostock T, Brandstrup B, Risius T, Meinertz T, Willems S : Correlation of symptoms to ECG diagnosis following atrial fibrillation ablation. J Cardiovasc Electrophysiol 2006 17 : 146 150.